The Th-17 response and its potential role in post-injury pulmonary complications

Travis L Holloway1, Martin G Schwacha

  • 1Department of Surgery, Division of Trauma and Emergency Surgery, The University of Texas Health Science Center San Antonio, TX 78229.

Insights

Trauma can cause acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Investigating T-helper 17 (Th-17) cells and IL-17 may reveal new treatments for post-trauma lung complications.

Area of Science:

  • Immunology
  • Critical Care Medicine
  • Public Health

Background:

  • Trauma is a significant cause of death and illness, often leading to costly ICU stays due to complications like acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
  • The precise mechanisms underlying trauma-related lung injury remain unclear, despite improvements in care.
  • Inflammatory processes, particularly those involving T-helper 17 (Th-17) cells and their cytokine IL-17, are implicated in lung injury and inflammatory diseases.

Purpose of the Study:

  • To explore the role of the novel T-helper 17 (Th-17) cell response in the pathogenesis of trauma-induced acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
  • To investigate the potential of Th-17 cells and IL-17 as biomarkers and therapeutic targets for post-traumatic lung complications.

Main Methods:

  • Review of current evidence on inflammatory cascades in trauma-related lung injury.
  • Examination of the role of T-helper cell subsets, specifically Th-17, in non-traumatic and inflammatory lung diseases.
  • Proposal for utilizing findings from animal models and human trauma victims' cytokine profiles.

Main Results:

  • Current evidence points to a pro-inflammatory cascade in trauma-related lung injury.
  • A novel T-cell response involving Th-17 cells and IL-17 is increasingly recognized in inflammatory lung diseases.
  • This Th-17 pathway presents a potential avenue for understanding ALI and ARDS pathogenesis.

Conclusions:

  • The Th-17 cell pathway and IL-17 cytokine represent a promising area for further research into the mechanisms of ALI and ARDS following trauma.
  • Understanding these specific immune responses could lead to the development of novel therapeutic strategies for preventing and treating ARDS in trauma patients.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...